ENDOTHELIN - POTENTIAL ROLE IN HYPERTENSION AND VASCULAR HYPERTROPHY

被引:216
|
作者
SCHIFFRIN, EL
机构
关键词
AORTA; ARTERIOLES; ENDOTHELIUM; HYPERTENSION; MINERALOCORTICOID; MALIGNANT; RNA; MESSENGER; RECEPTORS; ENDOTHELIN;
D O I
10.1161/01.HYP.25.6.1135
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The endothelins are a family of 21-amino acid peptides that are powerful vasoconstrictors. They may also induce vascular hypertrophy. These peptides may participate through these two mechanisms in the pathogenesis of the elevation of blood pressure and/or in the maintenance of hypertension in both experimental animal models and human essential hypertension. This review presents evidence both in favor and against the involvement of endothelins in hypertension. Plasma levels of endothelin-1 are either normal or slightly elevated in experimental and human essential hypertension. Responses of blood vessels to endothelin-1 may be normal or depressed in many models of experimental hypertension and also in essential hypertension in humans. It has recently been demonstrated that endothelin content and mRNA are increased in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. When endothelin receptor antagonists are administered chronically, elevation of blood pressure and development of vascular hypertrophy are blunted in this experimental model of hypertension. In contrast, spontaneously hypertensive rats do not exhibit any increase in either endothelin-1 mRNA or immunoreactive endothelin in blood vessels and fail to respond with lowering of blood pressure to long-term treatment with endothelin receptor antagonists. Blood pressure development in young spontaneously hypertensive rats is also unaffected by long-term administration of endothelin lin antagonists. Molecular genetic studies appear to support a genetic role of components of the endothelin system in Dahl salt-sensitive rats. In human essential hypertension, there is some evidence of activation of the endothelin system despite depressed responses of small arteries to endothelin-1 and normal circulating levels of endothelin-1. in plasma. Thus, a role of endothelins in high blood pressure is possible. Further research is necessary to establish in a more definitive way whether endothelins are involved in the pathophysiology of human essential hypertension.
引用
收藏
页码:1135 / 1143
页数:9
相关论文
共 50 条
  • [31] Endothelin: Role in experimental hypertension
    Schiffrin, EL
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 35 : S33 - S35
  • [32] Role of endothelin in human hypertension
    Touyz, RM
    Schiffrin, EL
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2003, 81 (06) : 533 - 541
  • [33] ROLE OF CARDIAC AND VASCULAR AMPLIFIERS IN THE MAINTENANCE OF HYPERTENSION AND THE EFFECT OF REVERSAL OF CARDIOVASCULAR HYPERTROPHY
    KORNER, PI
    JENNINGS, GL
    ESLER, MD
    BROUGHTON, A
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1985, 12 (03) : 205 - 209
  • [34] Role of Endothelin in the Induction of Cardiac Hypertrophy In Vitro
    Bupha-Intr, Tepmanas
    Haizlip, Kaylan M.
    Janssen, Paul M. L.
    PLOS ONE, 2012, 7 (08):
  • [35] Endothelin 1 and endothelin 3 in vascular-type portal hypertension
    Toledo, Carlos F.
    Carvente, Claudia T.
    Shigueoka, David C.
    Borges, Durval R.
    HEPATOLOGY, 2006, 44 (04) : 454A - 454A
  • [36] Vascular Endothelin and Hypertension - From Receptors to Medicine
    Beane, Sheree M.
    Khalil, Raouf A.
    CURRENT HYPERTENSION REVIEWS, 2005, 1 (02) : 101 - 113
  • [37] The role of endothelin A receptors in peripheral vascular control at rest and during exercise in patients with hypertension
    Craig, Jesse C.
    Broxterman, Ryan M.
    La Salle, D. Taylor
    Cerbie, James
    Ratchford, Stephen M.
    Gifford, Jayson R.
    Bunsawat, Kanokwan
    Nelson, Ashley D.
    Bledsoe, Amber D.
    Morgan, David E.
    Wray, D. Walter
    Richardson, Russell S.
    Trinity, Joel D.
    JOURNAL OF PHYSIOLOGY-LONDON, 2020, 598 (01): : 71 - 84
  • [38] Angiotensin II vascular hypertrophy is mediated by endothelin in vivo.
    Moreau, P
    Takase, H
    dUscio, LV
    Luscher, TF
    HYPERTENSION, 1996, 28 (03) : P58 - P58
  • [39] CELL BIOLOGY OF VASCULAR HYPERTROPHY IN SYSTEMIC HYPERTENSION
    DZAU, VJ
    GIBBONS, GH
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (11): : G30 - G35
  • [40] PREVALENCE AND DETERMINANTS OF CARDIAC AND VASCULAR HYPERTROPHY IN HYPERTENSION
    ROMAN, MJ
    PICKERING, TG
    PINI, R
    SCHWARTZ, JE
    DEVEREUX, RB
    HYPERTENSION, 1995, 26 (02) : 369 - 373